Market research
RKDA Arcadia Biosciences Inc
NASDAQ USD Consumer Defensive
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 349K
- P/E ratio
- Not available
- Analyst target
- 12
- Dividend yield
- Not available
- Beta
- 0.55
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- Not available
- Market cap
- 349K
- P/E ratio
- Not available
- Analyst target
- 12
- Dividend yield
- Not available
- Beta
- 0.55
About
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Research context
Arcadia Biosciences Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the RKDA discussion.
5 years, 6 months ago
Arcadia Biosciences, Inc is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.
From a valuation standpoint, the stock is 65.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.4.
Arcadia Biosciences, Inc's total revenue rose by 1613.9% to $7M since the same quarter in the previous year.
Its net income has increased by 242.5% to $9M since the same quarter in the previous year.
Finally, its free cash flow fell by 25.6% to $-7M since the same quarter in the previous year.
Based on the above factors, Arcadia Biosciences, Inc gets an overall score of 3/5.